Affimed
AFMD
AFMD was delisted on the 19th of May, 2025.
59 hedge funds and large institutions have $101M invested in Affimed in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 20 reducing their positions, and 7 closing their positions.
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
7% more funds holding
Funds holding: 55 → 59 (+4)
0% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 20
52% less capital invested
Capital invested by funds: $212M → $101M (-$111M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.6M |
| 2 |
PC
PointState Capital
New York
|
+$10.5M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$2.83M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.51M |
| 5 |
GP
GLG Partners
London,
United Kingdom
|
+$1.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$15.3M |
| 2 |
PA
Perceptive Advisors
New York
|
-$1.92M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.89M |
| 4 |
IHM
Iguana Healthcare Management
New York
|
-$1.35M |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.23M |
AFMD Hedge Fund Activity: Q3 2015 in Review
59 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Affimed (AFMD) for Q3 2015, worth a combined $101M — down 52% from $212M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new AFMD positions and 7 closed out — a net gain of 4 holders — while 20 added to existing stakes and 20 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $11.6M. The largest seller was OrbiMed, cutting an estimated $15.3M.
- 59 institutional investors held Affimed (AFMD) as of Q3 2015, up from 55 in Q2 2015.
- Funds reported $101M of Affimed stock for Q3 2015, down 52% quarter-over-quarter.
- 11 funds opened new Affimed positions in Q3 2015 and 7 closed out, a net change of +4 holders.
- The largest Affimed buyer in Q3 2015 was Fidelity Investments, an estimated $11.6M added.
- The largest Affimed seller in Q3 2015 was OrbiMed, an estimated $15.3M sold.
Based on aggregated 13F filings for Q3 2015.